Changes to the Code
S. 1774 · Protecting Minors in Federal Health Plans Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
5 U.S.C. § 8902 Contracting authority
1 change the bill asks for here, 1 carried out
- Carried out:
Section 8902 of title 5, United States Code, is amended by adding at the end the following:
(q) (1) In this subsection, the term “gender-affirming care or service”— (A) means a medical intervention designed to treat gender dysphoria; (B) includes hormone therapy, the use of puberty blockers, and any surgical procedure aimed at gender transition; and (C) notwithstanding …
§ 8902(o)–(q)
Start of § 8902 to (n)(2) unchanged ·
(o) A contract may not be made or a plan approved which includes coverage for any benefit, item, or service for which funds may not be used under the Assisted Suicide Funding Restriction Act of 1997.
(p) Each contract under this chapter shall require the carrier to comply with requirements described in the provisions of sections 2799A–1, 2799A–2, and 2799A–7 of the Public Health Service Act, sections 716, 717, and 722 of the Employee Retirement Income Security Act of 1974, and sections 9816, 9817, and 9822 of the Internal Revenue Code of 1986 (as applicable) in the same manner as such provisions apply to a group health plan or health insurance issuer offering group or individual health insurance coverage, as described in such sections. The provisions of sections 2799B–1, 2799B–2, 2799B–3, and 2799B–5 of the Public Health Service Act shall apply to a health care provider and facility and an air ambulance provider described in such respective sections with respect to an enrollee in a health benefits plan under this chapter in the same manner as such provisions apply to such a provider and facility with respect to an enrollee in a group health plan or group or individual health insurance coverage offered by a health insurance issuer, as described in such sections.
(q)
(1) [inserted: In this subsection, the term “gender-affirming care or service”—]
(A) [inserted: means a medical intervention designed to treat gender dysphoria;]
(B) [inserted: includes hormone therapy, the use of puberty blockers, and any surgical procedure aimed at gender transition; and]
(C) [inserted: notwithstanding subparagraphs (A) and (B), does not include—]
(i) [inserted: a service provided to an individual with a medically verifiable disorder of sexual development, including an individual with an irresolvable and ambiguous external sex characteristic, including an individual born with—]
(I) [inserted: 46 XY chromosomes and under-virilization;]
(II) [inserted: 46 XX chromosomes and virilization; or]
(III) [inserted: both ovarian and testicular tissue;]
(ii) [inserted: a service provided to treat a disorder diagnosed by a physician in which the physician has determined through genetic or biochemical testing that the applicable individual has abnormal (or otherwise inconsistent with typical male or female characteristics)—]
(I) [inserted: sex chromosome structure;]
(II) [inserted: sex steroid hormone production; or]
(III) [inserted: sex steroid hormone action;]
(iii) [inserted: the treatment of any infection, injury, disease, or disorder that has been caused or worsened by a medical intervention described in subparagraph (A), without regard to whether that intervention—]
(I) [inserted: was performed in compliance with State or Federal law; or]
(II) [inserted: was covered under a contract under this chapter, as of the date on which the intervention was performed;]
(iv) [inserted: any procedure that—]
(I) [inserted: is performed to address a physical disorder, injury, or illness that, as certified by a physician, poses an imminent risk of death or impairment of major bodily function; and]
(II) [inserted: is not performed for the purpose of gender transition or to alleviate psychological, physical, or mental distress relating to gender;]
(v) [inserted: a prescription for puberty suppression or blocking that is used to normalize puberty in an individual younger than 18 years of age who has been diagnosed with precocious puberty;]
(vi) [inserted: any hormone therapy procedure that is used to stimulate puberty in an individual younger than 18 years of age who has been diagnosed with delayed puberty, if the hormones administered through that procedure are—]
(I) [inserted: consistent with the biological sex of the individual; and]
(II) [inserted: used to stimulate a normal puberty consistent with the biological sex of the individual; or]
(vii) [inserted: male circumcision.]
(2) [inserted: Subject to paragraph (3), and notwithstanding any other provision of law or regulation, a contract under this chapter may not include coverage for any gender-affirming care or service for any individual younger than 18 years of age.]
(3) [inserted: In the case of an individual who, as of the effective date of this subsection, is younger than 18 years of age and who, as of that effective date, is undergoing hormone therapy that, as of the day before that effective date, is covered by a contract under this chapter, that hormone therapy may continue to be covered under such a contract after that effective date if the hormone therapy is provided pursuant to a reduction schedule that—]
(A) [inserted: is supervised by a physician; and]
(B) [inserted: requires that therapy to conclude not later than 1 year after that effective date.]